Poltreg S.A. (WSE:PTG)

Revenue by Product

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
T-regulated Lymphocyte	1.40M
T-regulated Lymphocyte Growth	40.04%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Poland	1.40M
Poland Growth	40.04%